Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Michael Guenther

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The American Surgeon|February 11, 2003
Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?Samantha Langer, J Michael Guenther, L Andrew DiFronzo
Vascular and Endovascular Surgery|December 31, 2005
Deciphering mesenteric venous thrombosis: imaging and treatmentAndre Grisham, Joann Lohr, J Michael Guenther, et al.
The American Surgeon|November 9, 2004
Lymphatic mapping improves staging and reduces morbidity in women undergoing total mastectomy for breast carcinomaSamantha Langer, J Michael Guenther, Philip I Haigh, et al.
The American Surgeon|February 14, 2006
Adverse drug reactions during lymphatic mapping and sentinel lymph node biopsy for solid neoplasmsDena Amr, Gregory Broderick-Villa, Philip I Haigh, et al.
Cancer Journal (Sudbury, Mass.)|December 26, 2002
Does tumor burden limit the accuracy of lymphatic mapping and sentinel lymph node biopsy in colorectal cancer?Gregor Broderick-Villa, Albert Ko, Theodore X O'Connell, et al.
Dermatology and Therapy|June 23, 2026
Comparing the i31-SLNB and the MIA Nomogram for Sentinel Lymph Node Biopsy Positivity Prediction in Cutaneous Melanoma: A Prospective Cohort AnalysisRohit Sharma, Rajan P Kulkarni, Richard Essner, et al.
Current Medical Research and Opinion|January 9, 2023
The 31-gene expression profile test informs sentinel lymph node biopsy decisions in patients with cutaneous melanoma: results of a prospective, multicenter studyMaki Yamamoto, Brenda Sickle-Santanello, Timothy Beard, et al.
Journal of Drugs in Dermatology : JDD|June 2, 2021
Clinical Considerations for Integrating Gene Expression Profiling into Cutaneous Squamous Cell Carcinoma ManagementSarah T Arron, Travis W Blalock, J Michael Guenther, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 7, 2003
Axillary dissection is not required for all patients with breast cancer and positive sentinel nodesJ Michael Guenther, Nora M Hansen, L Andrew DiFronzo, et al.
World Journal of Surgical Oncology|January 3, 2025
A prospective, multicenter analysis of the integrated 31-gene expression profile test for sentinel lymph node biopsy (i31-GEP for SLNB) test demonstrates reduced number of unnecessary SLNBs in patients with cutaneous melanomaJ Michael Guenther, Andrew Ward, Brian J Martin, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The American Surgeon|February 11, 2003
Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?Samantha Langer, J Michael Guenther, L Andrew DiFronzo
Vascular and Endovascular Surgery|December 31, 2005
Deciphering mesenteric venous thrombosis: imaging and treatmentAndre Grisham, Joann Lohr, J Michael Guenther, et al.
The American Surgeon|November 9, 2004
Lymphatic mapping improves staging and reduces morbidity in women undergoing total mastectomy for breast carcinomaSamantha Langer, J Michael Guenther, Philip I Haigh, et al.
The American Surgeon|February 14, 2006
Adverse drug reactions during lymphatic mapping and sentinel lymph node biopsy for solid neoplasmsDena Amr, Gregory Broderick-Villa, Philip I Haigh, et al.
Cancer Journal (Sudbury, Mass.)|December 26, 2002
Does tumor burden limit the accuracy of lymphatic mapping and sentinel lymph node biopsy in colorectal cancer?Gregor Broderick-Villa, Albert Ko, Theodore X O'Connell, et al.
Dermatology and Therapy|June 23, 2026
Comparing the i31-SLNB and the MIA Nomogram for Sentinel Lymph Node Biopsy Positivity Prediction in Cutaneous Melanoma: A Prospective Cohort AnalysisRohit Sharma, Rajan P Kulkarni, Richard Essner, et al.
Current Medical Research and Opinion|January 9, 2023
The 31-gene expression profile test informs sentinel lymph node biopsy decisions in patients with cutaneous melanoma: results of a prospective, multicenter studyMaki Yamamoto, Brenda Sickle-Santanello, Timothy Beard, et al.
Journal of Drugs in Dermatology : JDD|June 2, 2021
Clinical Considerations for Integrating Gene Expression Profiling into Cutaneous Squamous Cell Carcinoma ManagementSarah T Arron, Travis W Blalock, J Michael Guenther, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 7, 2003
Axillary dissection is not required for all patients with breast cancer and positive sentinel nodesJ Michael Guenther, Nora M Hansen, L Andrew DiFronzo, et al.
World Journal of Surgical Oncology|January 3, 2025
A prospective, multicenter analysis of the integrated 31-gene expression profile test for sentinel lymph node biopsy (i31-GEP for SLNB) test demonstrates reduced number of unnecessary SLNBs in patients with cutaneous melanomaJ Michael Guenther, Andrew Ward, Brian J Martin, et al.
Pageof 2